Efavirenz in children: WHO dosing guidelines raise the risk of side-effects in Thai children
Non-African middle-income countries pay four times more for ARVs than African middle-income countries
Darunavir/ritonavir safe and effective for younger children
Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children
Magical thinking? FEM-PrEP trial may have failed because participants used testing as prevention
Malaysia’s harm reduction programmes are preventing infections and saving money, but reaching far too few people who inject drugs
Fibroscan accurately predicts liver decompensation and death in HIV/HCV co-infected people
Studies look at bone changes during second-line therapy, fractures, and HIV- and HCV-related bone loss
